These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6854546)

  • 1. Effects of GTP on 3H-domperidone binding and its displacement by dopamine in rat striatal homogenates.
    Lazareno S
    J Recept Res; 1983; 3(1-2):163-75. PubMed ID: 6854546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium.
    Hamblin MW; Creese I
    Life Sci; 1982 May; 30(18):1587-95. PubMed ID: 7078356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.
    Grigoriadis D; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):21-5. PubMed ID: 2869417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates.
    de Vries DJ; Beart PM
    Brain Res; 1986 Jul; 387(1):29-35. PubMed ID: 3742232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride.
    Uzumaki H; Govoni S; Memo M; Carruba MO; Trabucchi M; Spano PF
    Brain Res; 1982 Sep; 248(1):185-7. PubMed ID: 7127137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X; Segawa T
    Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.
    Martres MP; Sokoloff P; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Nov; 143(1):101-7. PubMed ID: 3121365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE; Gessner GW; Crooke ST; Heys JR; Weinstock J
    Life Sci; 1986 Jun; 38(23):2087-96. PubMed ID: 2872567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
    Near JA; Mahler HR
    Neurochem Res; 1982 Jul; 7(7):831-7. PubMed ID: 7121724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
    Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
    Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-Dopamine binding sites differ in rat striatum and pituitary.
    Sokoloff P; Martres MP; Delandre M; Redouane K; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):221-7. PubMed ID: 6493362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.
    Urwyler S
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):374-82. PubMed ID: 2500603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors.
    Lévesque D; Di Paolo T
    Biochem Pharmacol; 1993 Feb; 45(3):723-33. PubMed ID: 8095140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 dopamine receptors in rat striatum are homogeneous as revealed by ligand-binding studies.
    Leonard MN; Halliday CA; Marriott AS; Strange PG
    Biochem Pharmacol; 1988 Nov; 37(22):4335-9. PubMed ID: 3196358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.